Skip to main content

Ginkgo Bioworks Holdings, Inc.

DNA
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001830214

In the last 90 days, Ginkgo Bioworks Holdings, Inc. insiders filed 0 open-market purchases and 6 sales; 182 institutions reported holding it in 13F filings for Q3 2026, worth $494.5M in total; Viking Global Investors is the only superinvestor holding it.

Key figures

Market capNo recent share count in SEC filings
–
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $962.5K in total
6
13F holdersQ3 2026, +1 vs. previous quarter
182
13F valueReported value at the end of Q3 2026
$494.5M
Superinvestors holdingAt the end of Q3 2026
1

Price chart

From SEC filings, in USD.

Revenue, FY2025
$170.2M
−25.1% year over year
Net income, FY2025
-$312.8M
No comparable prior period
Free cash flow, FY2025
-$178.7M
No comparable prior period
Revenue, Q3 FY2026
$27.7M
−28.6% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $312.8M (183.8% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
9.49M
Shares sold short
Change
+1.20M
+14.4% vs. previous
Days to cover
3.85
At average daily volume

Superinvestors holding DNA, Q3 2026

Go to the superinvestors tab

1 superinvestor reports holding Ginkgo Bioworks Holdings, Inc. on Form 13F. Percentages are the stock's share of each portfolio.

Viking Global Investors

Andreas Halvorsen

0.1%

Ginkgo Bioworks Holdings, Inc.'s share of the portfolio

Shares
2,900,025
Value
$37.2M

Latest insider trades

See all insider trades

Open-market purchases and sales by Ginkgo Bioworks Holdings, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 21, 2026 (view filing)4:07 PM ETOct 192 daysCoen Steven P.See remarksSSaleClass A Common Stock−766$10.14−$7.77K−1.5%50.2K after
Oct 21, 2026 (view filing)4:06 PM ETOct 192 daysCanton Barry10% OwnerSSaleClass A Common Stock−18.8K$10.14−$190.7K−5.0%356.3K afterDuplicate filing
Oct 21, 2026 (view filing)4:06 PM ETOct 192 daysCanton Barry10% OwnerSSaleClass A Common Stock−22.4K$10.14−$226.9K−4.7%454.0K afterDuplicate filing
Oct 21, 2026 (view filing)4:06 PM ETOct 192 daysShetty Reshma P.See remarksSSaleClass A Common Stock−22.4K$10.14−$226.9K−4.7%454.0K after
Oct 21, 2026 (view filing)4:06 PM ETOct 192 daysShetty Reshma P.See remarksSSaleClass A Common Stock−18.8K$10.14−$190.7K−5.0%356.3K after
Oct 21, 2026 (view filing)4:05 PM ETOct 192 daysKelly Jason RSee remarksSSaleClass A Common Stock−45.7K$10.14−$463.4K−26.1%129.1K after
Oct 7, 2026 (view filing)5:00 PM ETOct 52 daysCoen Steven P.See remarksSSaleClass A Common Stock−2.40K$15.00−$36.0K−4.6%49.4K after
Sep 16, 2026 (view filing)4:06 PM ETSep 151 dayHenry Christian ODirectorSSaleClass A Common Stock−5.00K$7.08−$35.4K−20.6%19.3K after
Aug 25, 2026 (view filing)5:01 PM ETAug 241 dayCoen Steven P.See remarksSSaleClass A Common Stock−330$6.98−$2.30K−0.6%51.9K after
Jul 20, 2026 (view filing)5:00 PM ETJul 173 daysCoen Steven P.See remarksSSaleClass A Common Stock−752$7.90−$5.94K−1.4%51.4K after

Top 10 13F holders, Q3 2026

See all 182 holders

The largest institutional positions in Ginkgo Bioworks Holdings, Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding DNA in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.4,519,135$58.0M0.00%+236,232+5.5%Added
Viking Global Investors LPSuperinvestorViking Global Investors2,900,025$37.2M0.11%−677,103−18.9%Reduced
Baillie Gifford & Co2,391,649$30.7M0.03%00.0%Unchanged
Erste Asset Management GmbH2,536,939$30.3M0.22%00.0%Unchanged
Vanguard Capital Management LLC2,109,962$27.1M0.00%+22,669+1.1%Added
Legal & General Group Plc1,812,398$23.3M0.00%+142,979+8.6%Added
Anchorage Capital Group, L.L.C.1,746,363$22.4M5.00%00.0%Unchanged
State Street Corp1,568,735$20.1M0.00%+96,365+6.5%Added
Vanguard Portfolio Management LLC1,457,573$18.7M0.00%+519,770+55.4%Added
Geode Capital Management, LLC1,278,332$16.4M0.00%+56,316+4.6%Added

Holders of 5% or more of DNA

See all 5 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ginkgo Bioworks Holdings, Inc..

Largest holders of DNA from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Shetty Reshma P.13D/A9.50%4.72M shares–Sep 27, 20215 filingsFeb 14, 2025SEC
BlackRock, Inc.13G/A7.70%4.12M shares+1.20 ppfrom 6.50%Jul 17, 20252 filingsJul 30, 2026SEC
Cascade Investment, L.L.C.13G/A6.20%3.32M shares−1.30 ppfrom 7.50%Sep 24, 20213 filingsNov 16, 2026SEC
Viking Global Investors LPSuperinvestorViking Global Investors13G/A5.40%2.90M shares−1.70 ppfrom 7.10%Sep 27, 20219 filingsNov 16, 2026SEC
Che Austin13G/A5.00%2.37M shares–Sep 27, 20215 filingsFeb 14, 2025SEC